Affiliates of Bain Capital and Hellman & Friedman struck a deal to buy the health IT company from its current private equity owners, Veritas Capital and an affiliate of activist investor Elliott Management. The two took the company private through a takeover bid in 2019.
The deal leaves Bain Capital with a minority stake in the company and values Waystar at $2.7 billion.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Earlier this year, Bloomberg News reported that Bain Capital was considering a sale of Waystar with Oracle and Visa named as two potential acquirers.
Cerevel will take on several clinical and preclinical candidates from Pfizer, which divested from neuroscience this year and will take a 25 percent stake in the new company.
Pierotti said the new funding will be used to bolster the company's sales and marketing team.
Washington-based Physio-Control will be integrated into Stryker’s emergency medical systems portfolio.
REACH Air Medical Services, part of the nation’s largest air medical transport network and Bain Capital-backed AirMedCare, is acquiring Oregon-based Emergency Airlift, giving the Northern California company broader, ahem, reach, into the Pacific Northwest. Terms of the deal were not disclosed. The acquisition will enable REACH to expand into the Bend region in central Oregon, […]
Bain Capital Ventures, a wing of the Boston private equity firm cofounded by Mitt Romney, has closed a new $600 million fund to invest in business, Internet and healthcare companies. This is Bain Capital Ventures’ fifth fund and its largest to date. Generally, the firm has put about half of its $2 billion-plus capital into […]
Five years after it first announced the desire to sell its emergency medical response business, Physio-Control, Medtronic (NYSE:MDT) has found a buyer in Bain Capital Ventures. The private equity firm will pay $487 million in cash to buy back ownership of the Redman, Washington-based business it sold to Medtronic in 1998 for $538 million. Physio-Control […]
Precision Therapeutics Inc. has raised $34 million in equity and options to further develop a test that helps identify an individual’s best chemotherapy options, according to a filing with the Securities and Exchange Commission. The company’s ChemoFX drug marker tests multiple chemotherapies on a patient’s cancer cells before treatment to determine which drugs are likely […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Bain Capital Ventures, which has invested in Midwestern health care start-ups, has raised a $525 million fund, its first since 2007.
Contract drug development organization Ricerca Biosciences LLC has agreed to acquire the discovery and preclinical business of MDS Pharma Services for $35 million less working capital and cap-ex reserve.
